The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemic

The COVID-19 pandemic has brought about valuable insights regarding models, data, and experiments. In this narrative review, we summarised the existing literature on these three themes, exploring the challenges of providing forecasts, the requirement for real-time linkage of health-related datasets, and the role of ‘experimentation’ in evaluating interventions. This literature review encourages us to broaden our perspective for the future, acknowledging the significance of investing in models, data, and experimentation, but also to invest in areas that are conceptually more abstract: the value of ‘team science’, the need for public trust in science, and in establishing processes for using science in policy. Policy-makers rely on model forecasts early in a pandemic when there is little data, and it is vital to communicate the assumptions, limitations, and uncertainties (theme 1). Linked routine data can provide critical information, for example, in establishing risk factors for adverse outcomes but are often not available quickly enough to make a real-time impact. The interoperability of data resources internationally is required to facilitate sharing across jurisdictions (theme 2). Randomised controlled trials (RCTs) provided timely evidence on the efficacy and safety of vaccinations and pharmaceuticals but were largely conducted in higher income countries, restricting generalisability to low- and middle-income countries (LMIC). Trials for non-pharmaceutical interventions (NPIs) were almost non-existent which was a missed opportunity (theme 3). Building on these themes from the narrative review, we underscore the importance of three other areas that need investment for effective evidence-driven policy-making. The COVID-19 response relied on strong multidisciplinary research infrastructures, but funders and academic institutions need to do more to incentivise team science (4). To enhance public trust in the use of scientific evidence for policy, researchers and policy-makers must work together to clearly communicate uncertainties in current evidence and any need to change policy as evidence evolves (5). Timely policy decisions require an established two-way process between scientists and policy makers to make the best use of evidence (6). For effective preparedness against future pandemics, it is essential to establish models, data, and experiments as fundamental pillars, complemented by efforts in planning and investment towards team science, public trust, and evidence-based policy-making across international communities. The paper concludes with a ‘call to actions’ for both policy-makers and researchers

Alternative medicine · Business · Data sharing · Interoperability · Narrative · Pandemic · Political science · Psychological intervention · Public relations · Computer Science · COVID-19 epidemiological studies · Health Policy Implementation Science · Medicine · Psychology · Viral Infections and Outbreaks Research

• Building an agile state-wide research infrastructure to address Covid-19 and emerging threats

  Open Access•Priya B Shete, Nicole Santos et al.•Frontiers in Public Health•2025

  Añadir item

• Forecasting the human cost of disasters under Sustainable Development Goal

  Open Access•Jamilah Ahmad, Irfan Ahmad et al.•Technology in Society•2025

  Añadir item

• Information Technology–Based Tracing Strategy in Response to Covid-19 in South Korea—Privacy Controversies

  Sangchul Park, Gina Choi et al.•JAMA•2020

  Añadir item

• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2

  Open Access•Merryn Voysey, Sue Ann Costa Clemens et al.•The Lancet•2021

  Añadir item

• Impact of community masking on Covid-19

  Open Access•Jason Abaluck, Laura H Kwong et al.•Science•2022

  Añadir item

• Ethnic differences in Sars-CoV-2 infection and Covid-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England

  Open Access•Rohini Mathur, Christopher T Rentsch et al.•The Lancet•2021

  Añadir item

• The WHO estimates of excess mortality associated with the Covid-19 pandemic

  Open Access•William Msemburi, Ariel Karlinsky et al.•Nature•2023

  Añadir item

• Misinformation About Covid-19 Vaccines on Social Media

  Open Access•Ingjerd Skafle, Anders Nordahl-Hansen et al.•Journal of Medical Internet…•2022

  Añadir item

• The Lancet Commission on lessons for the future from the Covid-19 pandemic

  Open Access•Jeff Sachs, Jeffrey D Sachs et al.•The Lancet•2022

  Añadir item

• School openings and the Covid-19 outbreak in Italy. A provincial-level analysis using the synthetic control method

  Open Access•Vincenzo Alfano, Salvatore Ercolano et al.•Health Policy•2021

  Añadir item

• Accuracy comparison of Arima and XGBoost forecasting models in predicting the incidence of Covid-19 in Bangladesh

  Open Access•Md Siddikur Rahman, Arman Hossain Chowdhury et al.•PLOS Global Public Health•2022

  Añadir item

• Asia's largest urban slum-Dharavi

  Open Access•Jyotsna Kaushal, Pooja Mahajan•Cities•2021

  Añadir item